India's Cadila Healthcare is aiming to triple monthly production of a Covid-19 vaccine candidate, ZyCoV-D, to as many as 30 million doses, its managing director said on Monday, as the country battles a massive wave of infections.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3fcdh6v
No comments:
Post a Comment